TokenPost·
Harmony Biosciences Shares Fall 7% as Wakix Patent Arguments Unfold
-7%
share decline
Arguments were underway Thursday in Wilmington, Delaware, in an ANDA patent case involving AET Pharma.
More news
- TokenPostChemung Financial Posts $2.63 EPS, $31.98M in Combined Net Interest and Noninterest Income
- TokenPostBranchOut Food Begins Underwritten Public Offering of Common Stock
- TokenPostGilead Agrees to Acquire PepStar’s Oral IL-23R Program for $1.275B
- TokenPostSallie Mae Reports About $375 Million in Revenue, $0.19 Per-Share Loss
- NewsBTCIrish Central Bank Fines Coinbase Unit €3.25 Million Over Customer Fund Safeguards
- Crypto BriefingBackpack founder outlines extreme tokenomics with no insider allocation